Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for L NAME
Most Correlated Studies
- Monocytes from patients with systemic sclerosis
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Hodgkin Reed-Sternberg cell lines KM-H2, L-428, L-540, L-1236, and HDLM-2
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Most Relevant Literature
- Decreased blood pressure with acute administration of quercetin in L-NAME-induced hypertensive rats.
- Long-term effects of sub-chronic exposure to L-NAME on reproductive system of male rats.
- Prolonged L-NAME exposure changes the vasodilator factor from NO to H2O2 in human arterioles in resp…
- Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension an…
- Curcumin Prevents Renal Damage of l-NAME Induced Hypertension in by Reducing MMP-2 and MMP-9.
Most Relevant Clinical Trials
- Safety and Efficacy of L-NAME and Midodrine to Increase MAP
- The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
- Generic vs. Name-Brand Levothyroxine
- Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)
- Exhaled Levels of Nitric Oxide
